Die Rechtsfolgenseite des § 84a Abs. 1 AMG – Inhalt und Grenzen des Auskunftsanspruchs

The article discusses the scope and limitations of the information claim according to Section 84a subsection 2 German Drug Act…

BGH: Reichweite und Grenzen der Kausalitätsvermutung des § 84 II AMG

Discussion of the judgement of the Federal Court of Justice (BGH,  26.03.2013 – VI ZR 109/12) regarding liability for medicinal products according to Section 84 German Drug Act…

Orphan Drugs: The Impact of EU Law

Describes EU legislation in the field of rare diseases…

Download PDF

Reichweite und Inhalt des neuen Auskunftsanspruchs der Krankenkassen nach § 129 Abs. 5c S. 4 SGB V

The article focuses on the question, how far the statutory health insurances’ right to information vis-à-vis pharmacies manufacturing cytostatic is reaching, in particular related to a potential right to information regarding the purchase prices of the pharmacies’  contract manufacturers…

Versprechen eines kostenlosen iPads bei Umsatzsteigerung durch eigene Produkte verstößt gegen § 7 Abs. 1 S. 1 HWG

Discussion of the judgement of the Higher Regional Court Karlsruhe (OLG Karlsruhe, 06.09.2012 – 4 U 110/12) regarding the provision of an IPad to a Healthcare Professional for free…

Rare Diseases policy

This essay highlights the main aspects of the of the European Commission’s proposal on Clinical Trials (COM 2012 369) and its relevance for rare diseases…

Download PDF